Newsroom

Healthcare Pharmaceutical Biotech

Stay informed with the latest in Healthcare, Pharmaceutical and Biotech press releases through our newsroom. Explore breaking updates, industry trends, and insights shaping these vital sectors—all in one place. Whether it’s innovation, regulatory changes, or breakthroughs, our newsroom keeps you connected to the stories that matter most.

All News

Dr. Drew Brown IV Introduces the
Healthcare & PharmaceuticalCompany Update

Dr. Drew Brown IV Introduces the "Surgery Last, Basics First" Standard for Better Health Decisions

February 24, 2026 7:00 AM

Dr. Drew Brown IV, MD, FAAOS, a board-certified and fellowship-trained orthopedic spine surgeon based in Tampa, Florida, is encouraging individuals to adopt a personal standard he uses as a consistent decision filter in spine care: start with the basics, measure progress, and escalate only when the fundamentals have been given a real chance.Brown's standard, called "Surgery Last, Basics First," is designed to help people improve outcomes in...

Read more
Amphastar Announces FDA Approval for Ipratropium Bromide HFA
Healthcare & PharmaceuticalRegulatory

Amphastar Announces FDA Approval for Ipratropium Bromide HFA

February 24, 2026 6:00 AM

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the U.S. Food and Drug Administration ("FDA") has approved the Company's Abbreviated New Drug Application ("ANDA") for Ipratropium Bromide HFA Inhalation Aerosol 17mcg/actuation. The FDA determined that Amphastar's Ipratropium Bromide HFA Inhalation Aerosol is bioequivalent and therapeutically equivalent to Boehringer Ingelheim's Atrovent® HFA Inhalation Aerosol.Additionally, the FDA...

Read more
Psyence Group Inc. Enters into Amending Agreement to Extend Amalgamation Timeline with GoldCoast Resource Corp.
Healthcare & PharmaceuticalCompany Update

Psyence Group Inc. Enters into Amending Agreement to Extend Amalgamation Timeline with GoldCoast Resource Corp.

February 24, 2026 6:00 AM

Psyence Group Inc. (CSE:PSYG) ("Psyence" or the "Company") announces that it has entered into an amending agreement (the "Amending Agreement") dated February 24, 2026 with GoldCoast Resource Corp. ("GoldCoast") and Psyence Therapeutics Corp., a wholly owned subsidiary of Psyence ("Psyence Subco"), to amend the definitive amalgamation agreement dated November 21, 2025 (the "Amalgamation Agreement"), as previously announced by the Company on...

Read more
Simulab Launches TraumaMan(R) System Ultrasound Module for Realistic Trauma Training
Healthcare & PharmaceuticalProduct Announcements

Simulab Launches TraumaMan(R) System Ultrasound Module for Realistic Trauma Training

February 24, 2026 5:00 AM

Simulab Corporation, a leader in soft-tissue simulation for over 30 years, announced the launch of the TraumaMan® System Ultrasound Module, which expands ultrasound-enabled training capabilities within its flagship trauma training platform.Developed in direct response to feedback from the healthcare simulation community, the new module integrates ultrasound imaging into the TraumaMan System to facilitate realistic, hands-on training for critical...

Read more
Avant Brands Announces Timing of Release of Fiscal 2025 Annual Results
Healthcare & PharmaceuticalCompany Update

Avant Brands Announces Timing of Release of Fiscal 2025 Annual Results

February 23, 2026 4:30 PM

Avant Brands Inc. (TSX:AVNT)(OTCQX:AVTBF)(FRA:1BU0) ("Avant" or the "Company"), a leading producer of innovative and award-winning cannabis products, announced that it will release its fourth quarter and full year 2025 financial results before market open on Monday, March 2, 2026.The financial results and any accompanying materials will be available on SEDAR+ at www.sedarplus.ca and on the Company's website in the Investors section.About Avant...

Read more
NHI Announces Appointment of Lilly H. Donohue to the Board of Directors
Healthcare & PharmaceuticalRegulatory

NHI Announces Appointment of Lilly H. Donohue to the Board of Directors

February 23, 2026 4:05 PM

National Health Investors, Inc. (NYSE:NHI) announced today that Lilly H. Donohue has been appointed to the NHI Board of Directors effective February 17, 2026. Ms. Donohue's appointment follows an extensive search performed by a third party executive and board recruitment firm.Ms. Donohue is currently President and CEO of Everstory Partners (formerly StoneMor Inc.). Prior to joining Everstory Partners in November 2022, Ms. Donohue served as the...

Read more
Olympian Gabby Thomas, BetterWay(TM) Blood Testing to Host 'Track Like Gabby' Happy Hour During SXSW
Healthcare & PharmaceuticalConferences

Olympian Gabby Thomas, BetterWay(TM) Blood Testing to Host 'Track Like Gabby' Happy Hour During SXSW

February 23, 2026 12:40 PM

BetterWay™ blood testing by Babson Diagnostics, a science-first healthcare technology company transforming diagnostic blood testing, today announced it will host "Track Like Gabby x BetterWay: Sprint Toward Better Patient Care Happy Hour" on Friday, March 13, 2026, from 6:00-8:00 p.m. at The Capital Factory (located in the Omni Hotel at 701 Brazos Street, Austin, TX) in the ACL Room (16th floor).Designed for healthcare innovators, leaders and...

Read more
Hermes Health Introduces Boutique Medicine Program in Chicago and Surrounding Suburbs with a 12-Month Commitment to Personalized Health
Healthcare & PharmaceuticalAdvertorial

Hermes Health Introduces Boutique Medicine Program in Chicago and Surrounding Suburbs with a 12-Month Commitment to Personalized Health

February 23, 2026 12:10 PM

As concierge medicine gains traction across the country, Hermes Health is bringing this patient-centered model to Chicago communities for individuals seeking a more attentive, relationship-based approach to healthcare-one that blends modern medical innovation with the values of traditional, personalized care.Led by Dr. Nesreen Hermes, Medical Director, and Rene Hermes, Chief Operating Officer, the practice is reshaping how patients experience...

Read more
TRNR Updates FAQ's, Publishes New Investor Deck With 50% Increase of 2026 Pro Forma Revenue Guidance To More Than $30M
Healthcare & PharmaceuticalCompany Update

TRNR Updates FAQ's, Publishes New Investor Deck With 50% Increase of 2026 Pro Forma Revenue Guidance To More Than $30M

February 23, 2026 10:10 AM

Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or the "Company"), maker of innovative specialty fitness equipment under the Wattbike, CLMBR and FORME brands, today announced it had updated its FAQs and Investor Presentation, highlighting the increase of its 2026 pro forma revenue guidance of more than $30 million. The Company urges all shareholders to review the information and updates carefully.TRNR Investor...

Read more
Medical Care Technologies, Inc. (OTC PINK:MDCE) Unveils New Corporate Logo & Structure Ahead of Consumer AI App Launch
Healthcare & PharmaceuticalCompany Update

Medical Care Technologies, Inc. (OTC PINK:MDCE) Unveils New Corporate Logo & Structure Ahead of Consumer AI App Launch

February 23, 2026 9:30 AM

Medical Care Technologies, Inc. (OTC PINK:MDCE) today announced the adoption of a new corporate logo as the Company prepares for the launch of its first consumer-based artificial intelligence mobile application, Snapshot Recipes.The newly adopted logo reflects the Company's expanding focus on AI-driven mobile applications in lifestyle, wellness, and medical pre-screening technologies. The refreshed brand identity aligns with Medical Care...

Read more
MentalHealth.com Calls for Realignment in Social Media and Mental Health
Healthcare & PharmaceuticalCompany Update

MentalHealth.com Calls for Realignment in Social Media and Mental Health

February 23, 2026 9:00 AM

As legal and regulatory scrutiny intensifies over the mental health effects of media and technology, MentalHealth.com said the sector is entering a period of accountability.Over the past two decades, media systems built to connect the world expanded at historic speed, outpacing society's understanding of their psychological impact. Platforms originally designed for expression and community evolved into environments optimized for engagement -...

Read more
DataVault AI and Wellgistics Health Announce Plans to Expand Partnership to Include Healthcare Delivery Intellectual Property for Healthcare as a Service (HaaS) Blockchain-enabled Smart Contracts
Healthcare & PharmaceuticalPartnerships

DataVault AI and Wellgistics Health Announce Plans to Expand Partnership to Include Healthcare Delivery Intellectual Property for Healthcare as a Service (HaaS) Blockchain-enabled Smart Contracts

February 23, 2026 8:30 AM

Datavault AI Inc. (NASDAQ:DVLT)("Datavault AI"), a provider of data monetization, credentialing, digital engagement, and real-world asset tokenization technologies, and Wellgistics Health, Inc. (NASDAQ:WGRX) ("Wellgistics"), a health information technology leader, integrating proprietary pharmacy dispensing optimization artificial intelligence (‘AI') platform EinsteinRx™ into its patented blockchain-enabled smart contracts platform...

Read more
Ensysce Biosciences Invited to Participate in Upcoming Scientific and Industry Events
Healthcare & PharmaceuticalCompany Update

Ensysce Biosciences Invited to Participate in Upcoming Scientific and Industry Events

February 23, 2026 8:00 AM

Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical-stage pharmaceutical company developing innovative solutions for novel therapeutics while reducing the potential for abuse and overdose, today announced that members of its executive management team including Dr. Lynn Kirkpatrick, Dr. William Schmidt and Mr. Geoff Birkett have been invited to participate in upcoming scientific and industry events focused on...

Read more
Black Book Research Publishes
Healthcare & PharmaceuticalProduct Announcements

Black Book Research Publishes "Germany: State of Acute Care EHR and Digital Health 2026"

February 23, 2026 6:00 AM

Black Book announced the publication of Germany: State of Acute Care EHR and Digital Health 2026, a qualitative market report intended to support hospital executives, CIO leadership, agency administration, investors, clinical stakeholders, and procurement teams evaluating acute-care EHR/HIS (KIS) modernization and vendor selection in Germany. This report is part of the2026 Black Book series of country-centric research on the status of healthcare...

Read more
Cantargia to Participate in TD Cowen's Annual Healthcare Conference
Healthcare & PharmaceuticalCompany Update

Cantargia to Participate in TD Cowen's Annual Healthcare Conference

February 23, 2026 3:15 AM

Cantargia AB (publ) (Nasdaq Stockholm:CANTA)(STO:CANTA) today announced that members of Cantargia's management will participate in and host 1-1 meetings at TD Cowen's 46th Annual Health Care Conference, March 2-4, 2026, in Boston.For further information, please contactHilde Steineger, CEOTelephone: +46 (0)46-275 62 60E-mail: [email protected] CantargiaCantargia AB (publ), reg. no. 556791-6019, is a biotechnology company that develops...

Read more
Hemogenyx Pharmaceuticals PLC Announces Exercise of Warrants and Issue of Equity
Healthcare & PharmaceuticalRegulatory

Hemogenyx Pharmaceuticals PLC Announces Exercise of Warrants and Issue of Equity

February 23, 2026 2:15 AM

Hemogenyx Pharmaceuticals plc (LSE:HEMO) announces that it has received notices to exercise warrants over50,841new ordinary shares in the Company (the "Warrant Shares").The Company has received notices to exercise warrants over50,841new Ordinary Shares at exercise prices ranging from180p to350p,raising£118,632 forthe Company.Admission and Total Voting RightsApplication will be made for the Warrant Shares, which will rank pari passu in all...

Read more
TRNR Publishes CEO Letter Discussing Recent Deal & Company Next Steps
Healthcare & PharmaceuticalCompany Update

TRNR Publishes CEO Letter Discussing Recent Deal & Company Next Steps

February 20, 2026 10:58 AM

Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or the "Company"), maker of innovative specialty fitness equipment under the Wattbike, CLMBR and FORME brands, today published a letter from the CEO commenting on the Company's most recent acquisition; the required-but-not-desired reverse split; Sportstech loan enforcement; and his perspective on TRNR's road forward from here. The Company encourages investors to read and review the letter...

Read more
ForCast Orthopedics Announces Upcoming Media Events
Healthcare & PharmaceuticalCompany Update

ForCast Orthopedics Announces Upcoming Media Events

February 20, 2026 10:00 AM

ForCast Orthopedics, a development-stage company focused on modernizing care for complex orthopedic infections, today announced that its team and technology will be featured in upcoming media events produced by the Anterior Hip Foundation (AHF) and the Journal of Orthopaedic Experience & Innovation (JOEI).The AHF podcast series From Idea to Market is a 12-episode, documentary-style series exploring how medical innovation happens. The series...

Read more
MDCE CEO Expands Open-Market Position to 66,199,283 Shares After Previously Returning Nearly 2 Billion Shares to Treasury
Healthcare & PharmaceuticalCompany Update

MDCE CEO Expands Open-Market Position to 66,199,283 Shares After Previously Returning Nearly 2 Billion Shares to Treasury

February 20, 2026 9:30 AM

Medical Care Technologies Inc. (OTC Pink:MDCE) (the "Company") today announced that its Chief Executive Officer, Marshall Perkins, purchased 16,199,283 shares of MDCE common stock on the open market at a purchase price of $0.0002 per share in a series of transactions last week.The shares were acquired using Mr. Perkins' personal funds and represent a direct open-market investment. No new shares were issued by the Company in connection with this...

Read more
Andrew Cannestra, MD PhD Urges Healthcare Leaders to Rethink Innovation from the Ground Up
Healthcare & PharmaceuticalCompany Update

Andrew Cannestra, MD PhD Urges Healthcare Leaders to Rethink Innovation from the Ground Up

February 20, 2026 9:10 AM

Dr. Andrew Cannestra, MD PhD, a physician-scientist and healthcare strategist, is calling for a renewed focus on clear thinking, systems awareness, and usability in healthcare innovation. Drawing from his cross-disciplinary career in medicine, data science, and clinical product development, Cannestra believes the path forward isn't more disruption - it's better execution."Innovation doesn't matter if no one uses it," said Dr. Cannestra. "We...

Read more

Join the thousands of ACCESS Newswire customers today who are getting millions of views on their news.


Check out our flexible subscription and pay as you go pricing

and packages.

Use Code NEWS10 for 10% off  of your first purchase.


Latest Blog Posts

Visit our blogs for press release tips, media engagement

Strategies, and Product Comparisons.

Executive delivering prepared remarks from an earnings call script
By Jennifer Hammers July 9, 2026
How to write earnings call prepared remarks that land — structure, length, the safe-harbor open, non-GAAP language, and building remarks around your strategy.
IR
By Brian Balbirnie July 8, 2026
A practical earnings call preparation checklist for IR teams — the two-week runway, consensus, logistics, Q&A prep, and Reg FD-clean disclosure timing.
ACCESS Newswire guide on AI investor relations — how AI assistants read company earnings disclosures
By Jennifer Hammers July 6, 2026
AI assistants read your earnings within minutes. Learn how IR teams make disclosures AI-readable — and how the LLM Citation Score measures your visibility.
What does Meltwater cost in 2026, and what are the alternatives? Meltwater resells press release dis
By Jennifer Hammers June 22, 2026
What does Meltwater cost in 2026, and what are the alternatives? See how ACCESS Newswire compares on distribution, data, and price.
A logo for accesswire next to a logo for rack
By Jennifer Hammers June 21, 2026
Compare Muck Rack vs ACCESS Newswire on pricing, features, and alternatives. See how ACCESS Newswire adds distribution, pitching, and analytics.
A blue and white logo with a check mark next to it
By Jennifer Hammers June 19, 2026
Compare Business Wire vs ACCESS Newswire on pricing and capabilities — and how ACCESS delivers comparable reach at a fraction of the cost.
Show More




Discover the news
by Industry:


Need help with your PR Strategy?
Learn more about our
professional PR Services today:

.MEDIA PRO 
Want to get noticed
by the Media but don’t
know how? 

.TOTAL PRO

Need full support to 

Optimize your PR

Efforts?